Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement With Santen Pharmaceutical Co., Ltd for Arvn001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema
- Latest
- Detail
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
17:19
Shenzhen Invt Electric: The company currently has no core component products for humanoid robots.
Shenzhen Invt Electric+3.32%
17:19
China Pacific Insurance: Cumulative life insurance premium income is 228.8 billion yuan.
China Pacific Insurance-2.52%
17:18
SINO BIOPHARM announced on the Hong Kong Stock Exchange that the injection of Alectinib mesylate has been approved for listing.
SINO BIOPHARM+0.90%